N/A Completed N=24

Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy

central serous chorioretinopathy

Source: ClinicalTrials.gov NCT00803517 ↗

Enrolled (actual)

Serious AEs

—

Results posted

Dec 2008

Primary outcomePrimary: Multifocal Electroretinogram Amplitudes — 28.4; 32.2; 29.7; 36.1 microvolts

Summary

This study is a comparison of multifocal electroretinogram assessment between the laser treatment group and the photodynamic therapy group in chronic central serous chorioretinopathy.

Outcome Measures

Outcome	Result	p-value
PRIMARY Multifocal Electroretinogram Amplitudes	28.4; 32.2; 29.7; 36.1; 39.9; 37.6	—
SECONDARY Best Corrected Visual Acuity	0.22; 0.15; 0.07; 0.08; 0.05; 0.04	—

Eligibility Criteria

Inclusion Criteria

CSC (over 3 months) when subretinal fluid persisted in the subfoveal region demonstrated by clinical examination and OCT
Ability to maintain steady fixation for mfERG
Presence of abnormal dilated choroidal vasculature in ICGA
Symptom duration over 3 months

Exclusion Criteria

Previous PDT or laser treatment history
Evidence of CNV in FAG
Other chorioretinal disorders that can cause macular exudation such as age-related macular degeneration, pathologic myopia, angioid streaks, trauma, inflammatory diseases, retinal vasculopathies, and hereditary dystrophies

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00803517). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.